Kangmei Pharma | 600518 - Operating Profit

Stock Price
1.59
Daily Change
-0.02 -1.24%
Monthly
-9.14%
Yearly
-20.90%
Q2 Forecast
1.59

Kangmei Pharma reported CNY-26.7M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Genomma Lab Internacional MXN 874.42M 73.81M Mar/2026
Hypermarcas BRL 647.2M 26.39M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD 217M 171M Dec/2025
Revvity USD 82.77M 63.06M Mar/2026
Sh Fosun Pharma CNY 817.9M 46.25M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Wuxi Apptec CNY 5.11B 435.53M Mar/2026
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026